Impact of oral contraceptive use and menstrual phases on patellar tendon morphology, biochemical composition and biomechanical properties in female athletes

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Impact of oral contraceptive use and menstrual phases on patellar tendon morphology, biochemical composition and biomechanical properties in female athletes. / Hansen, Mette Damborg; Couppe, Christian; Hansen, Christina; Skovgaard, Dorthe; Kovanen, Vuokko; Larsen, Jytte Overgaard; Aagaard, Per; Magnusson, S Peter; Kjaer, Michael.

In: Journal of Applied Physiology, Vol. 114, 21.02.2013, p. 998-1008.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Hansen, MD, Couppe, C, Hansen, C, Skovgaard, D, Kovanen, V, Larsen, JO, Aagaard, P, Magnusson, SP & Kjaer, M 2013, 'Impact of oral contraceptive use and menstrual phases on patellar tendon morphology, biochemical composition and biomechanical properties in female athletes', Journal of Applied Physiology, vol. 114, pp. 998-1008. https://doi.org/10.1152/japplphysiol.01255.2012

APA

Hansen, M. D., Couppe, C., Hansen, C., Skovgaard, D., Kovanen, V., Larsen, J. O., Aagaard, P., Magnusson, S. P., & Kjaer, M. (2013). Impact of oral contraceptive use and menstrual phases on patellar tendon morphology, biochemical composition and biomechanical properties in female athletes. Journal of Applied Physiology, 114, 998-1008. https://doi.org/10.1152/japplphysiol.01255.2012

Vancouver

Hansen MD, Couppe C, Hansen C, Skovgaard D, Kovanen V, Larsen JO et al. Impact of oral contraceptive use and menstrual phases on patellar tendon morphology, biochemical composition and biomechanical properties in female athletes. Journal of Applied Physiology. 2013 Feb 21;114:998-1008. https://doi.org/10.1152/japplphysiol.01255.2012

Author

Hansen, Mette Damborg ; Couppe, Christian ; Hansen, Christina ; Skovgaard, Dorthe ; Kovanen, Vuokko ; Larsen, Jytte Overgaard ; Aagaard, Per ; Magnusson, S Peter ; Kjaer, Michael. / Impact of oral contraceptive use and menstrual phases on patellar tendon morphology, biochemical composition and biomechanical properties in female athletes. In: Journal of Applied Physiology. 2013 ; Vol. 114. pp. 998-1008.

Bibtex

@article{fa17f2e63b7f41369bb3cde054cfda0e,
title = "Impact of oral contraceptive use and menstrual phases on patellar tendon morphology, biochemical composition and biomechanical properties in female athletes",
abstract = "Introduction: Gender differences exist with regards to ligament and tendon injuries. Lower collagen synthesis has been observed in exercising females vs. males, and in users of oral contraceptives (OC) vs non-users, but it is unknown if OC will influence tendon biomechanics of females undergoing regular training. Material and Method: 30 female athletes (handball players, 18-30 yrs) were recruited: Fifteen long-term users of OC (7.0±0.6 yrs) and 15 non-users (> 5 yrs). Synchronized values of patellar tendon elongation (obtained by ultrasonography) and tendon force were sampled during ramped isometric knee extensor MVC to estimate mechanical tendon properties. Further, tendon cross-sectional area and length were measured from MRI images, and tendon biopsies were obtained for analysis of tendon fibril characteristics and collagen cross-linking. Results: Overall, no difference in tendon biomechanical properties, tendon fibril characteristics or collagen cross-linking was observed between the OC-users and non-users, or between the different phases of the menstrual cycle. In athletes, tendon CSA in the preferred jumping leg tended to be larger than the contra-lateral leg (p=0.09), and a greater absolute (p=0.01) and normalized tendon stiffness (p=0.02), as well as a lower strain (p=0.04) were observed in the jumping leg compared to the contra-lateral leg. Conclusion: The results indicate that long-term OC use or menstrual phases does not influence structure or mechanical properties of the patellar tendon in female team handball athletes.",
author = "Hansen, {Mette Damborg} and Christian Couppe and Christina Hansen and Dorthe Skovgaard and Vuokko Kovanen and Larsen, {Jytte Overgaard} and Per Aagaard and Magnusson, {S Peter} and Michael Kjaer",
year = "2013",
month = feb,
day = "21",
doi = "10.1152/japplphysiol.01255.2012",
language = "English",
volume = "114",
pages = "998--1008",
journal = "Journal of Applied Physiology",
issn = "8750-7587",
publisher = "American Physiological Society",

}

RIS

TY - JOUR

T1 - Impact of oral contraceptive use and menstrual phases on patellar tendon morphology, biochemical composition and biomechanical properties in female athletes

AU - Hansen, Mette Damborg

AU - Couppe, Christian

AU - Hansen, Christina

AU - Skovgaard, Dorthe

AU - Kovanen, Vuokko

AU - Larsen, Jytte Overgaard

AU - Aagaard, Per

AU - Magnusson, S Peter

AU - Kjaer, Michael

PY - 2013/2/21

Y1 - 2013/2/21

N2 - Introduction: Gender differences exist with regards to ligament and tendon injuries. Lower collagen synthesis has been observed in exercising females vs. males, and in users of oral contraceptives (OC) vs non-users, but it is unknown if OC will influence tendon biomechanics of females undergoing regular training. Material and Method: 30 female athletes (handball players, 18-30 yrs) were recruited: Fifteen long-term users of OC (7.0±0.6 yrs) and 15 non-users (> 5 yrs). Synchronized values of patellar tendon elongation (obtained by ultrasonography) and tendon force were sampled during ramped isometric knee extensor MVC to estimate mechanical tendon properties. Further, tendon cross-sectional area and length were measured from MRI images, and tendon biopsies were obtained for analysis of tendon fibril characteristics and collagen cross-linking. Results: Overall, no difference in tendon biomechanical properties, tendon fibril characteristics or collagen cross-linking was observed between the OC-users and non-users, or between the different phases of the menstrual cycle. In athletes, tendon CSA in the preferred jumping leg tended to be larger than the contra-lateral leg (p=0.09), and a greater absolute (p=0.01) and normalized tendon stiffness (p=0.02), as well as a lower strain (p=0.04) were observed in the jumping leg compared to the contra-lateral leg. Conclusion: The results indicate that long-term OC use or menstrual phases does not influence structure or mechanical properties of the patellar tendon in female team handball athletes.

AB - Introduction: Gender differences exist with regards to ligament and tendon injuries. Lower collagen synthesis has been observed in exercising females vs. males, and in users of oral contraceptives (OC) vs non-users, but it is unknown if OC will influence tendon biomechanics of females undergoing regular training. Material and Method: 30 female athletes (handball players, 18-30 yrs) were recruited: Fifteen long-term users of OC (7.0±0.6 yrs) and 15 non-users (> 5 yrs). Synchronized values of patellar tendon elongation (obtained by ultrasonography) and tendon force were sampled during ramped isometric knee extensor MVC to estimate mechanical tendon properties. Further, tendon cross-sectional area and length were measured from MRI images, and tendon biopsies were obtained for analysis of tendon fibril characteristics and collagen cross-linking. Results: Overall, no difference in tendon biomechanical properties, tendon fibril characteristics or collagen cross-linking was observed between the OC-users and non-users, or between the different phases of the menstrual cycle. In athletes, tendon CSA in the preferred jumping leg tended to be larger than the contra-lateral leg (p=0.09), and a greater absolute (p=0.01) and normalized tendon stiffness (p=0.02), as well as a lower strain (p=0.04) were observed in the jumping leg compared to the contra-lateral leg. Conclusion: The results indicate that long-term OC use or menstrual phases does not influence structure or mechanical properties of the patellar tendon in female team handball athletes.

U2 - 10.1152/japplphysiol.01255.2012

DO - 10.1152/japplphysiol.01255.2012

M3 - Journal article

C2 - 23429870

VL - 114

SP - 998

EP - 1008

JO - Journal of Applied Physiology

JF - Journal of Applied Physiology

SN - 8750-7587

ER -

ID: 44703381